Nayax rises 13.9% on $350 million IPS acquisition deal
- Nayax Ltd shares rose 13.9% to $52.61 on $350 million IPS acquisition
- Moderna gained 9.9% to $152.64 following analyst upgrades on oncology data
- Madison Air Solutions jumped 14.5% after $2.25 billion private placement
- Rezolve AI rose 18.1% as Google selected its proprietary database technology
- Marvell Technology climbed 6.5% amid raised analyst price targets

*this image is generated using AI for illustrative purposes only.
U.S. stocks rose on Tuesday, with the Nasdaq Composite gaining around 150 points. Nayax Ltd (NASDAQ: NYAX) led notable gainers after agreeing to acquire smart parking technology provider IPS Group Inc for $350 million in cash.
The payments company will acquire IPS from Windjammer Capital Investors on a cash-free, debt-free basis. The purchase price equals about 17 times IPS’ estimated 2026 adjusted EBITDA. That multiple falls to about 12 times after expected synergies.
Nayax shares jumped 13.9% to $52.61 during the session.
Other Notable Gainers
Several other stocks recorded significant gains across sectors including biotechnology, technology, and infrastructure.
| Company | Ticker | Gain | Price | Key Driver |
|---|---|---|---|---|
| Capricor Therapeutics | CAPR | 21.5% | $8.26 | Market movement |
| Rezolve AI PLC | RZLV | 18.1% | $2.87 | Google selects database tech |
| Critical Metals Corp | CRML | 15.3% | $7.70 | Market movement |
| Madison Air Solutions | MAIR | 14.5% | $28.58 | $2.25 billion private placement |
| Methode Electronics | MEI | 12.1% | $15.72 | Market movement |
| AbCellera Biologics | ABCL | 11.7% | $11.85 | Market movement |
| Immatics NV | IMTX | 10.5% | $9.62 | $150 million offering announced |
| Everspin Technologies | MRAM | 10.4% | $17.82 | Market movement |
Moderna Inc (NASDAQ: MRNA) rose 9.9% to $152.64 as Wall Street analysts upgraded ratings following landmark Phase 3 oncology data. Wolfe Research upgraded the stock Tuesday morning, following a similar move by BofA Securities last week to raise its price target to $170.
Cadeler A/S – ADR (NYSE: CDLR) rose 8.9% to $26.11 after reporting a year-over-year increase in second-quarter financial results and affirming FY26 sales guidance above estimates.
Pacific Biosciences of California Inc (NASDAQ: PACB) climbed 8.5% to $1.39. Richtech Robotics Inc (NASDAQ: RR) gained 8.3% to $1.76 after announcing a $12 million buyback plan.
EyePoint Inc (NASDAQ: EYPT) rose 7.2% to $5.22. Super Micro Computer Inc (NASDAQ: SMCI) gained 7.2% to $37.69 as risk appetite remained firm. Eikon Therapeutics Inc (NASDAQ: EIKN) gained 6.7% to $11.91.
Marvell Technology Inc (NASDAQ: MRVL) rose 6.5% to $244.30. Rosenblatt analyst Sajal Dogra maintained the stock with a Buy and raised the price target from $240 to $300. Susquehanna analyst Christopher Rolland maintained the stock with a Positive and raised the price target from $230 to $265.
Real Brokerage Inc (NASDAQ: REAX) rose 5.3% to $25.26. Real REMAX Group completed the Real-RE/MAX business combination and authorized a share repurchase program of up to $450 million.
How will Nayax's acquisition of IPS Group impact its integration timeline and ability to realize the projected $350 million synergy savings?
Will Moderna's Phase 3 oncology data success trigger a broader re-rating of biotech stocks currently trading below their historical valuation multiples?
Does the surge in Rezolve AI following Google's selection signal a sustained trend in enterprise adoption of specialized database technologies?

































